Sciformix Among the ‘Top 20 Most Promising Pharma and Life Sciences Solution Providers’

Sciformix selected by a panel of experts based on criteria for outstanding performance in areas such as industry solutions, innovation, client satisfaction and overall company performance

22 April 2016, Boston, MASciformix Corporation has been recognized as one of the Top 20 Most Promising “Pharma & Life Sciences Solution Providers – 2016” in a recent feature by Silicon India. The companies were selected by a panel of experts based on select criteria for outstanding performance in areas such as industry solutions, innovation, client satisfaction and overall company performance.

The 20 Most Promising “Pharma & Life Sciences Solutions Providers – 2016” recognition was created by Silicon India, with a vision to help pharmaceutical and life sciences companies find the best partner and highlight the outstanding service providers in this domain. The life sciences industry has been witnessing significant global growth, creating unprecedented opportunities for outsourcing activities to niche and specialized providers and utilizing optimized processes in areas such as drug safety, regulatory affairs and clinical operations. These domain-intensive processes require strong subject matter expertise which is where SPOs (Scientific Process Organizations) such as Sciformix contribute. By using analytics and processes as enablers, Sciformix provides value through its industry focus, domain competency, depth of subject matter expertise and commitment to quality.

A distinguished panel of the industry’s top most CIOs, CEOs, VCs and other experts including Silicon India’s Editorial Board scrutinized the list of companies on different business criteria. According to the judges, ‘The distinguished offering in the space of SPO, with a dedication to provide scientific knowledge-based services to foster efficiency and quality, is what makes Sciformix unique from others. It helps clients reduce their regulatory and business risks by bringing experience that bears positive results and enhances client value.’

This acknowledgment demonstrates how Sciformix has addressed the market and its clients’ needs by providing “best-in-class” scientific services to life science organizations. These services span the entire product life cycle, from pre-clinical to clinical to post-marketing activities. On the announcement of the recognition, President and CEO of Sciformix, Manish Soman, commented ‘We are deeply honored to be included in this list, and humbled to be in the company of such innovative and accomplished solution providers.”

He added “Our mission is to be the preferred partner for global life sciences companies. We want to continue providing high quality scientific knowledge-based expertise that delivers quality results and improves efficiencies across the entire product lifecycle. Our overarching objective has always been to improve the quality of patient treatment worldwide. This recognition is a testament that we are in fact living our mission”.

Sciformix, headquartered in the US, with operations in the UK, India and Philippines, partners with life science clients to provide a full range of services from study design to post-marketing surveillance and commercialization support. Areas of specialization include Safety and Risk Management, Clinical Research & Post Approval Support, Medical Affairs, Scientific Writing and Regulatory Affairs services.

To view the full list of companies selected by Silicon India visit 20 Most Promising Pharma Life Sciences Solution Providers. To view the write-up about Sciformix visit Sciformix: A Unique Scientific Process Organization Built on Knowledge and Process Excellence.

To learn more about Sciformix visit www.sciformix.com , email us at ask@sciformix.com, or call us at +1.877.576.5005.

For further press information please contact: Scott Girling-Heathcote, The Scott Partnership: + 44 1477 539539 mail to sciformix@scottpr.com or Susan Najjar, Director of Marketing, Sciformix Corporation: + 1 617-264-0339 mail to susan.najjar@sciformix.com.

About Sciformix

Sciformix Corporation is a leading Scientific Process Organization (SPO), providing scientific knowledge-based services to pharmaceutical and biopharmaceutical, generics, consumer products, medical devices and other healthcare companies – in the areas of Safety and Risk Management, Clinical Research & Post-Approval Support and Regulatory Affairs.  Our mission is to partner with global life science companies to provide high quality scientific knowledge-based expertise to deliver better quality outcomes and improved efficiencies across the entire product lifecycle with the ultimate objective of improving quality of healthcare for patients worldwide. Corporate headquarters is located in Westborough, MA with operations in USA, UK, India and the Philippines.

We create value for our clients through our singular focus on the life sciences industry, strong pharmaceutical domain competency, exceptional subject matter expertise, industry reputed advisory board, uncompromising focus on quality, process rigor, predictable results, and ability to scale. Our portfolio of services spans the full spectrum of product lifecycle from pre-clinical and clinical to post marketing activities to help our customers solve complex analytical challenges, improve the quality of patient healthcare and increase client productivity.

Sciformix is dedicated to providing our clients outstanding services and solutions, fuelled by an unrivalled commitment to quality. We share the same level of involvement, dedication and passion as our clients and become an integral part of their team.  Our distinct combination of scientific expertise, process rigor and technology innovation delivers consistent, reliable and insightful results.  Our ability to scale and grow to meet your evolving needs means we are flexible and dedicated to your success in delivering safe products with more efficiency and greater speed. We help you make the right decisions at the right time by providing Trusted Services Built on Science.